The use of eidronate disodium in the prevention of heterotopic ossification in burn patients

Burns

Volumn 34, Issue 3, 2008, Pages 355-360

  Shafer, David M ^a   Bay, Curt ^b   Caruso, Daniel M ^c   Foster, Kevin N ^c  

^a MAYO CLINIC   (United States)

^b A T STILL UNIVERSITY   (United States)

^c MARICOPA MEDICAL CENTER   (United States)

Author keywords

Burn; Etidronate disodium; Heterotopic ossification

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID; SALICYLIC ACID DERIVATIVE; WARFARIN;

ARTICLE; BURN; CALCIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HETEROTOPIC OSSIFICATION; HUMAN; INJURY SEVERITY; MALE; PROPHYLAXIS; RETROSPECTIVE STUDY;

ADULT; BONE DENSITY CONSERVATION AGENTS; BURNS; EPIDEMIOLOGIC METHODS; ETIDRONIC ACID; FEMALE; HUMANS; MALE; OSSIFICATION, HETEROTOPIC;

EID: 40749147514     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2007.04.006     Document Type: Article

References (58)

1. Richards A.M., and Klaassen M.F. Heterotopic ossification after severe burns: a report of three cases and review of the literature. Burns 23 1 (1997) 64-68
2. Peterson S.L., et al. Postburn heterotopic ossification: insights for management decision making. J Trauma 29 3 (1989) 365-369
3. Munster A.M., et al. Heterotopic calcification following burns: a prospective study. J Trauma 12 12 (1972) 1071-1074
4. Evans E.B. Heterotopic bone formation in thermal burns. Clin Orthop Relat Res 263 (1991) 94-101
5. Elledge E.S., et al. Heterotopic bone formation in burned patients. J Trauma 28 5 (1988) 684-687
6. Evans E.B. Orthopaedic measures in the treatment of severe burns. J Bone Joint Surg Am 48 4 (1966) 643-669
7. VanLaeken N., et al. Heterotopic bone formation in the patient with burn injuries. A retrospective assessment of contributing factors and methods of investigation. J Burn Care Rehabil 10 4 (1989) 331-335
8. Tepperman P., et al. Heterotopic ossification n burns. J Burn Care Rehabil 5 4 (1984) 283-287
9. Crawford C.M., et al. Heterotopic ossification: are range of motion exercises contraindicated?. J Burn Care Rehabil 7 4 (1986) 323-327
10. Pruitt Jr. B.A. Complications of thermal injury. Clin Plast Surg 1 4 (1974) 667-691
11. Kubacek V., Fait M., and Poul J. A case of heterotopic ossification in the hip joint area following skin burn. Acta Chir Plast 19 3-4 (1977) 209-214
12. Jay M.S., et al. Bone and joint changes following burn injury. Clin Pediatr (Phila) 20 11 (1981) 734-736
13. Heslop J.H. Heterotopic periarticular ossification in burns. Burns Incl Therm Inj 8 6 (1982) 436-438
14. Edlich R.F., et al. Heterotopic calcification and ossification in the burn patient. J Burn Care Rehabil 6 4 (1985) 363-368
15. Tsionos I., Leclercq C., and Rochet J.M. Heterotopic ossification of the elbow in patients with burns. Results after early excision. J Bone Joint Surg Br 86 3 (2004) 396-403
16. Ring D., and Jupiter J.B. Operative release of ankylosis of the elbow due to heterotopic ossification. Surgical technique. J Bone Joint Surg Am 86-A Suppl. 1 (2004) 2-10
17. Gaur A., et al. Heterotopic ossification around the elbow following burns in children: results after excision. J Bone Joint Surg Am 85-A 8 (2003) 1538-1543
18. Brooke M.M., et al. Heterotopic ossification and peripheral nerve entrapment: early diagnosis and excision. Arch Phys Med Rehabil 72 6 (1991) 425-429
19. Peters W.J. Heterotopic ossification: can early surgery be performed, with a positive bone scan?. J Burn Care Rehabil 11 4 (1990) 318-321
20. Agarwal M. Radiation therapy for the prevention of heterotopic ossification at the elbow. J Bone Joint Surg Br 84 2 (2002) 305 author reply
21. Banovac K., et al. Prevention and treatment of heterotopic ossification after spinal cord injury. J Spinal Cord Med 27 4 (2004) 376-382
22. Galus R., Wlodarski P.K., and Wlodarski K.H. Fluvastatin increases heterotopically induced ossicles in mice. Clin Exp Pharmacol Physiol 33 4 (2006) 388-390
23. Michelsson J.E., et al. Methylprednisolone has a preventive effect on heterotopic bone formation and on knee thickening and stiffening following manipulation of immobilized rabbit legs. Clin Exp Rheumatol 12 4 (1994) 409-413
24. Padgett D.E., et al. The efficacy of 500 CentiGray radiation in the prevention of heterotopic ossification after total hip arthroplasty: a prospective, randomized, pilot study. J Arthroplasty 18 6 (2003) 677-686
25. Seegenschmiedt M.H., Makoski H.B., and Micke O. Radiation prophylaxis for heterotopic ossification about the hip joint-a multicenter study. Int J Radiat Oncol Biol Phys 51 3 (2001) 756-765
26. Ayers D.C., Evarts C.M., and Parkinson J.R. The prevention of heterotopic ossification in high-risk patients by low-dose radiation therapy after total hip arthroplasty. J Bone Joint Surg Am 68 9 (1986) 1423-1430
27. Francis M.D., Russell R.G., and Fleisch H. Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo. Science 165 899 (1969) 1264-1266
28. Licata A.A. Discovery, clinical development, and therapeutic uses of bisphosphonates. Ann Pharmacother 39 4 (2005) 668-677
29. Banovac K., et al. Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification. Paraplegia 31 10 (1993) 660-666
30. Banovac K., and Gonzalez F. Evaluation and management of heterotopic ossification in patients with spinal cord injury. Spinal Cord 35 3 (1997) 158-162
31. Banovac K., Gonzalez F., and Renfree K.J. Treatment of heterotopic ossification after spinal cord injury. J Spinal Cord Med 20 1 (1997) 60-65
32. Banovac K. The effect of etidronate on late development of heterotopic ossification after spinal cord injury. J Spinal Cord Med 23 1 (2000) 40-44
33. Spielman G., Gennarelli T.A., and Rogers C.R. Disodium etidronate: its role in preventing heterotopic ossification in severe head injury. Arch Phys Med Rehabil 64 11 (1983) 539-542
34. Stover S.L., Niemann K.M., and Miller III J.M. Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal-cord injury patients. J Bone Joint Surg Am 58 5 (1976) 683-688
35. Stover S.L., Hahn H.R., and Miller III J.M. Disodium etidronate in the prevention of heterotopic ossification following spinal cord injury (preliminary report). Paraplegia 14 2 (1976) 146-156
36. Hurvitz E.A., et al. Risk factors for heterotopic ossification in children and adolescents with severe traumatic brain injury. Arch Phys Med Rehabil 73 5 (1992) 459-462
37. Biering-Sorensen F., and Tondevold E. Indomethacin and disodium etidronate for the prevention of recurrence of heterotopic ossification after surgical resection. Two case reports. Paraplegia 31 8 (1993) 513-515
38. Finerman G.A., and Stover S.L. Heterotopic ossification following hip replacement or spinal cord injury. Two clinical studies with EHDP. Metab Bone Dis Relat Res 3 4-5 (1981) 337-342
39. Yutani Y., et al. Clinical effect of etidronate disodium (EHDP) on heterotopic ossification following total hip arthroplasty. Osaka City Med J 41 2 (1995) 63-73
40. Freed J.H., et al. The use of the three-phase bone scan in the early diagnosis of heterotopic ossification (HO) and in the evaluation of Didronel therapy. Paraplegia 20 4 (1982) 208-216
41. Thomas B.J., and Amstutz H.C. Results of the administration of diphosphonate for the prevention of heterotopic ossification after total hip arthroplasty. J Bone Joint Surg Am 67 3 (1985) 400-403
42. Thomas B.J., and Amstutz H.C. Prevention of heterotopic bone formation: clinical experience with diphosphonates. Hip (1987) 59-69
43. Garland D.E., et al. Diphosphonate treatment for heterotopic ossification in spinal cord injury patients. Clin Orthop Relat Res 176 (1983) 197-200
44. Hu H.P., et al. The effect of biphosphonate on induced heterotopic bone. Clin Orthop Relat Res 272 (1991) 259-267
45. Hu H.P., Slooff T.J., and van Horn J.R. Heterotopic ossification following total hip arthroplasty: a review. Acta Orthop Belg 57 2 (1991) 169-182
46. Haran M., Bhuta T., and Lee B. Pharmacological interventions for treating acute heterotopic ossification. Cochrane Database Syst Rev 4 (2004) CD003321
47. Ono K., et al. A double-blind study of EHDP on heterotopic ossification after spinal cord injury using placebo. [Japenese]. Rinsho Hyoka [Clin Eval] 16 4 (1988) 581-615
48. Lippin Y., et al. Vocal cords dysfunction resulting from heterotopic ossification in a patient with burns. J Burn Care Rehabil 15 2 (1994) 169-173
49. Kolar J., and Vrabec R. Periarticular soft-tissue changes as a late consequence of burns. J Bone Joint Surg Am 41-A 1 (1959) 103-111
50. Schiele H.P., Hubbard R.B., and Bruck H.M. Radiographic changes in burns of the upper extremity. Radiology 104 1 (1972) 13-17
51. Esselman P.C., et al. Burn rehabilitation: state of the science. Am J Phys Med Rehabil 85 4 (2006) 383-413
52. Fleisch H. Mechanisms of action of the bisphosphonates. Medicina (B Aires) 57 Suppl. 1 (1997) 65-75
53. Carano A., et al. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro. J Clin Invest 85 2 (1990) 456-461
54. Reszka A.A., and Rodan G.A. Mechanism of action of bisphosphonates. Curr Osteoporos Rep 1 2 (2003) 45-52
55. Rogers M.J. New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des 9 32 (2003) 2643-2658
56. Dunn C.J., Fitton A., and Sorkin E.M. Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs Aging 5 6 (1994) 446-474
57. Singer F.R., and Minoofar P.N. Bisphosphonates in the treatment of disorders of mineral metabolism. Adv Endocrinol Metab 6 (1995) 259-288
58. Silverman S.L., et al. Rachitic syndrome after disodium etidronate therapy in an adolescent. Arch Phys Med Rehabil 75 1 (1994) 118-120